Blog
Now offering Pluvicto for metastatic castration-resistant prostate cancer
Roper St. Francis Healthcare is now offering Pluvicto, an advanced targeted therapy for metastatic castration-resistant prostate cancer. This innovative treatment expands options for patients and provides specialized, comprehensive prostate cancer care close to home from a trusted multidisciplinary team.
Read More